A Study Investigating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Ascending Single Doses of Orally Administered VRA-175 in Healthy Adult Subjects.
Phase of Trial: Phase I
Latest Information Update: 24 May 2011
At a glance
- Drugs MR 1817 (Primary)
- Indications Pain
- Focus Adverse reactions
- 24 May 2011 Actual end date (Jan 2011) added as reported by ClinicalTrials.gov.
- 24 May 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 26 Jul 2010 Status changed from not yet recruiting to recruiting added as reported by ClinicalTrials.gov.